These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1542379)

  • 1. Age-related deficits of central muscarinic cholinergic receptor function in the mouse: partial restoration by chronic piracetam treatment.
    Stoll L; Schubert T; Müller WE
    Neurobiol Aging; 1992; 13(1):39-44. PubMed ID: 1542379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro down-regulation predicts agonist efficacy at central muscarinic cholinergic receptors.
    Stoll L; Müller WE
    Biochem Pharmacol; 1991 Jun; 41(12):1963-6. PubMed ID: 2039547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line.
    Haddad EB; Rousell J; Mak JC; Barnes PJ
    Br J Pharmacol; 1995 Oct; 116(3):2027-32. PubMed ID: 8640341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of phorbol ester- and agonist-induced down-regulation of astrocyte receptors coupled to inositol phospholipid metabolism.
    Pearce B; Morrow C; Murphy S
    J Neurochem; 1988 Mar; 50(3):936-44. PubMed ID: 2828550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of muscarinic M1 receptors of murine neuroblastoma cells (clone N1E-115) without receptor down-regulation and protein kinase C activity.
    Kanba S; Kanba KS; McKinney M; Pfenning M; Abraham R; Nomura S; Enloes L; Mackey S; Richelson E
    Biochem Pharmacol; 1990 Sep; 40(5):1005-14. PubMed ID: 2167677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of piracetam administration on 3H-N-methylscopolamine binding in cerebral cortex of young and old rats.
    Viana GS; Marinho MM; Sousa FC
    Life Sci; 1992; 50(13):971-7. PubMed ID: 1548981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced desensitization of cholinergically stimulated phosphoinositide breakdown is independent of endogenously activated protein kinase C in HT-29 human colon carcinoma cells.
    Kopp R; Mayer P; Pfeiffer A
    Biochem J; 1990 Jul; 269(1):73-8. PubMed ID: 2165399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
    Hu J; Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal muscarinic cholinergic and nitric oxide systems in cardiovascular regulation.
    Feldman DS; Terry AV; Buccafusco JJ
    Eur J Pharmacol; 1996 Oct; 313(3):211-20. PubMed ID: 8911917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.
    Thompson AK; Fisher SK
    J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and agonist regulation of muscarinic ([3H]N-methyl scopolamine) receptors in isolated ventricular myocytes from rat.
    Horackova M; Robinson B; Wilkinson M
    J Mol Cell Cardiol; 1990 Nov; 22(11):1273-83. PubMed ID: 2283685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line.
    Abello J; Ye F; Bosshard A; Bernard C; Cuber JC; Chayvialle JA
    Endocrinology; 1994 May; 134(5):2011-7. PubMed ID: 8156901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Correlation with down-regulation of cell surface receptors.
    Cioffi CL; el-Fakahany EE
    Biochem Pharmacol; 1989 Jun; 38(11):1827-34. PubMed ID: 2544180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between desensitization and sequestration of muscarinic cholinergic receptors in two neuronal cell lines.
    Baumgold J; Cooperman BB; White TM
    Neuropharmacology; 1989 Nov; 28(11):1253-61. PubMed ID: 2556656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
    Masters SB; Quinn MT; Brown JH
    Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The muscarinic receptor agonist L-658,903 modulates the in vivo accumulation of inositol monophosphates in mouse brain.
    Patel S; Freedman SB
    Eur J Pharmacol; 1994 May; 267(3):329-34. PubMed ID: 8088372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic localization of muscarinic cholinergic receptors in visual areas of cat brain: variations in sensitivity of N-[3H]methylscopolamine binding sites to carbachol and pirenzepine.
    Cymerman U; Palacios JM; Cortés R; Skangiel-Kramska J
    Neurosci Lett; 1987 Oct; 81(1-2):13-8. PubMed ID: 3696462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex.
    Ek B; Antonsson BM
    Acta Physiol Scand; 1993 Mar; 147(3):289-95. PubMed ID: 8386426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subchronic administration of pyritinol on receptor deficits and phosphatidylinositol metabolism in the brain of the aged mouse.
    Hartmann H; Cohen SA; Müller WE
    Neuropharmacology; 1993 Feb; 32(2):119-25. PubMed ID: 8450941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.